About Oculogica
Oculogica is a Healthcare company based in New York (United States) founded in 2013. Eye-tracking technology is utilized to detect traumatic brain injuries. It operates in the Healthcare and Technology sectors. Oculogica has raised $21.98 million across 7 funding rounds from investors including HHS and TitletownTech. Oculogica offers products and services including EyeBOX. Its focus areas include Life Sciences, Neurology, Medical Devices and Screening Devices. Its competitors include C. Light Technologies, Neurotrack and Neuralight; 3 of its 3 listed competitors have raised funding.
Company details
Oculogica was founded in 2013 and is based in New York, United States. Operations focus on the medical technology sector, where eye-tracking solutions are developed to assess brain function. The EyeBox CNS device, authorized by the FDA, aids in concussion diagnosis by identifying cranial nerve weaknesses without requiring baseline data or calibration. Four patents are held, along with three working papers, supporting pathology location and nature analysis.
- Headquarters New York, United States
- SectorsHealthcareTechnology
- Website oculogica.com
- Social LinkedIn X Facebook
- Total Equity Funding$21.98M (USD)
in 7 rounds
- Latest Funding Round$7.57M (USD), Series B
Apr 2024
- InvestorsHHS
& 1 more
Products & Services of Oculogica
Oculogica offers a comprehensive portfolio of products and services, including EyeBOX.
Measures eye movements for rapid, non-invasive concussion detection.
Funding Insights of Oculogica
Oculogica has successfully raised a total of $21.98M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $7.57 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.98M
- Total Rounds 7
- Last Round Series B — $7.57M
- First Round $599,970
(Jul 2014)
- Investors Count 2
All 7 funding rounds of Oculogica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $7.57M | Series B | – | – | – |
| Mar 2022 | $4.05M | Series A | – | – | – |
| Mar 2022 | Debt – Conventional | – | – | – | |
| Jan 2020 | $8.07M | Series A | – | TitletownTech | – |
| Jun 2018 | $552,676 | Grant | – | – | |
| Mar 2016 | $1.69M | Series A | – | – | – |
| Jul 2014 | $599,970 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Oculogica
Oculogica has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and TitletownTech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| titletowntech.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Oculogica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oculogica
11 people are tracked at Oculogica (3 in leadership, 4 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Joel Sanderson | Chief Technology Officer | Leadership |
Rosina Samadani | CEO | Leadership |
Rosina S. | President And CEO | Leadership |
Kathryn Swintek | Advisor | Board & advisors |
Jill Enos | Advisor | Board & advisors |
P. Laxminarain | Advisor | Board & advisors |
Uzma Samadani | Founder & Scientific Advisor | Board & advisors |
Dan Sanderson | Principal Engineer | Team |
Darryl Mayeaux (he/him) | Data Scientist | Team |
Samantha Marquez | Operations Assistant | Team |
David Lorek | Senior Software Engineer | Team |
Complete people profiles for Oculogica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oculogica
3 dated milestones of Oculogica across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Oculogica is founded.
- Funding First funding round of $600K.
- Funding Latest funding round, Series B, of $7.6M.
Competitors of Oculogica
Oculogica has 3 listed competitors in our database, 3 of them funded. They include C. Light Technologies, Neurotrack and Neuralight.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| clighttechnologies.com | 2014 | Berkeley, United States | $2.5M | Eye-tracking devices are developed for neurodegenerative disease monitoring. | ||
| neurotrack.com | 2012 | Redwood, United States | $57.81M | Neurological disorders are diagnosed using eye-tracking assessment tools. | ||
| neuralight.ai | 2021 | San Francisco, United States | $30.5M | AI-based neurological evaluation and assessment tool for diagonosis |
Detailed competitors of Oculogica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Oculogica
The website of Oculogica (oculogica.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 12.4% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Oculogica (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oculogica
Complete news archive for Oculogica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oculogica
Oculogica was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Oculogica is headquartered in New York, United States. It is registered at New York, New York, United States.
Oculogica is a funded company, having raised a total of $21.98M across 7 funding rounds to date. The company's 1st funding round was a Seed of $599.97K, raised on Jul 2014.
Oculogica was founded in 2013 and is based in New York, United States. Operations focus on the medical technology sector, where eye-tracking solutions are developed to assess brain function. The EyeBox CNS device, authorized by the FDA, aids in concussion diagnosis by identifying cranial nerve weaknesses without requiring baseline data or calibration. Four patents are held, along with three working papers, supporting pathology location and nature analysis.
Oculogica's top competitors include Neurotrack, Neuralight and C. Light Technologies.
Oculogica offers EyeBOX.
Oculogica has 2 investors. Key investors include HHS, and TitletownTech.